Apimeds Pharmaceuticals US Inc (APUS)

$1.30 -0.04 (-2.99%)
Market Cap 18.36M
Revenue (ttm) 0.00
Net Income (ttm) -6.00M
EPS (ttm) N/A
PE Ratio 0.00
Forward PE N/A
Profit Margin 0.00%
Debt to Equity Ratio 0.05
Volume 50,288
Avg Vol 281,572
Day's Range N/A - N/A
Shares Out 12.58M
Stochastic %K 1%
Beta N/A
Analysts Strong Buy
Price Target N/A

Company Profile

Apimeds Pharmaceuticals US, Inc. provides digital asset treasury solutions in bitcoin treasury infrastructure. The company is based in Ras al-Khaimah, the United Arab Emirates. Apimeds Pharmaceuticals US, Inc. operates as a subsidiary of Inscobee., Inc.

Industry: Drug Manufacturers - Specialty & Generic
Sector: Healthcare
Address:
B4-204A5, Business Centre 04, RAKEZ Business Zone-FZ, Ras al-Khaimah, United Arab Emirates
CoffeeRocks
CoffeeRocks May. 13 at 2:52 PM
$APUS Any price tag with recent dilution 10/1 RS Recently might affect the stock in the short term, looked at the financial, saw the RS
0 · Reply
JasonNewton
JasonNewton May. 9 at 7:21 PM
AMS is moving from an investment-heavy phase into a revenue-harvesting phase. The combination of: * expanding treatment centers, * rising direct patient revenue, * improving utilization, * international growth hopes, * and an extremely low float AMS hot watch. $ATXG $APUS $AGPU /.
0 · Reply
Bibby12
Bibby12 May. 8 at 3:10 PM
$APUS anybody understand share structure and Pipe.
1 · Reply
David_M_
David_M_ May. 8 at 4:12 AM
$APUS Up from here!
0 · Reply
CoffeeRocks
CoffeeRocks May. 7 at 8:22 PM
$CODX $GOVX $VRAX $APUS $BTAI Return of the BIO tickers
0 · Reply
Goat888
Goat888 May. 7 at 7:13 PM
$APUS I wanted to buy but people said 2 digits so I stopped
1 · Reply
Bibby12
Bibby12 May. 7 at 6:27 PM
$APUS bought some at 1.42. Not sure what the next catalyst will be but seems oversold at this point.
0 · Reply
Pinkfloyd35
Pinkfloyd35 May. 7 at 12:48 AM
$APUS total turd, don’t buy this .
0 · Reply
Nat21
Nat21 May. 6 at 11:48 PM
$APUS the companey which merged with $NAKA run from 0.60s to 30 plus dollars pre-merger. I hope we see a good run on $APUS before merger.
0 · Reply
TeeBee909
TeeBee909 May. 6 at 3:42 PM
$APUS not much needed (ask) for $3.X
0 · Reply
Latest News on APUS
Apimeds Pharmaceuticals US Settles with Inscobee; Merger Proceeds, $100 Million PIPE Financing to Close, and Lōkahi Therapeutics to Advance Apitox Program

May 5, 2026, 2:07 PM EDT - 8 days ago

Apimeds Pharmaceuticals US Settles with Inscobee; Merger Proceeds, $100 Million PIPE Financing to Close, and Lōkahi Therapeutics to Advance Apitox Program

Inscobee, Apimeds Korea deliver action by written consent to remove directors

2026-03-25T11:21:47.000Z - 7 weeks ago

Inscobee, Apimeds Korea deliver action by written consent to remove directors

Apimeds Pharma US reports material breach of merger agreement by Inscobee

2026-03-24T12:35:14.000Z - 7 weeks ago

Apimeds Pharma US reports material breach of merger agreement by Inscobee

Apimeds Pharmaceuticals US Inc. Announces Material Breach of Merger Agreement by Inscobee Inc. (KS:006490) and Apimeds Inc.; Prepares Filing Emergency Action in Delaware Court of Chancery

Mar 24, 2026, 8:30 AM EDT - 7 weeks ago

Apimeds Pharmaceuticals US Inc. Announces Material Breach of Merger Agreement by Inscobee Inc. (KS:006490) and Apimeds Inc.; Prepares Filing Emergency Action in Delaware Court of Chancery

Apimeds Pharmaceuticals confirms FDA Type C meeting for osteoarthritis candidate

2026-02-11T21:55:14.000Z - 3 months ago

Apimeds Pharmaceuticals confirms FDA Type C meeting for osteoarthritis candidate

Apimeds Pharmaceuticals and Lōkahi Therapeutics Announce FDA Type C Meeting Scheduled for LT‑100 (Apitox)

Feb 11, 2026, 4:51 PM EST - 3 months ago

Apimeds Pharmaceuticals and Lōkahi Therapeutics Announce FDA Type C Meeting Scheduled for LT‑100 (Apitox)

Apimeds Pharmaceuticals and MindWave Innovations Announce Closing of $100MM PIPE Financing and Activation of 1,000 Bitcoin to Power AI-Driven Yield Generation Strategy

Dec 10, 2025, 9:58 AM EST - 5 months ago

Apimeds Pharmaceuticals and MindWave Innovations Announce Closing of $100MM PIPE Financing and Activation of 1,000 Bitcoin to Power AI-Driven Yield Generation Strategy

Apimeds Pharmaceuticals US Inc trading resumes

2025-12-01T14:50:10.000Z - 5 months ago

Apimeds Pharmaceuticals US Inc trading resumes

Apimeds Pharmaceuticals, MindWave Innovations announce merger

2025-12-01T14:35:27.000Z - 5 months ago

Apimeds Pharmaceuticals, MindWave Innovations announce merger

Apimeds and MindWave Announce Merger, Integrating Biotech Growth with AI-Driven Digital Treasury Yield Generation Backed by $100M PIPE

Dec 1, 2025, 9:25 AM EST - 5 months ago

Apimeds and MindWave Announce Merger, Integrating Biotech Growth with AI-Driven Digital Treasury Yield Generation Backed by $100M PIPE

Apimeds Pharmaceuticals US Inc trading halted, news pending

2025-12-01T14:05:31.000Z - 5 months ago

Apimeds Pharmaceuticals US Inc trading halted, news pending

Apimeds Brings ai² Futures Lab™ to the Palouse — Partnering with the University of Idaho to Shape the Future of Biotech Innovation

Nov 10, 2025, 10:00 AM EST - 6 months ago

Apimeds Brings ai² Futures Lab™ to the Palouse — Partnering with the University of Idaho to Shape the Future of Biotech Innovation

Apimeds Pharmaceuticals expands AI Futures Lab program

2025-10-14T09:30:18.000Z - 7 months ago

Apimeds Pharmaceuticals expands AI Futures Lab program

Apimeds Pharmaceuticals says “I love my Ducks” with new ai² Futures Lab™ Program collaboration with the University of Oregon's Lundquist College of Business

Oct 14, 2025, 3:02 AM EDT - 7 months ago

Apimeds Pharmaceuticals says “I love my Ducks” with new ai² Futures Lab™ Program collaboration with the University of Oregon's Lundquist College of Business

Apimeds Expands ai² Future Labs Program to Include University of San Diego Students in Biotech Business Development

Sep 15, 2025, 6:24 PM EDT - 8 months ago

Apimeds Expands ai² Future Labs Program to Include University of San Diego Students in Biotech Business Development

Apimeds Pharmaceuticals issues statement on FDA draft guidance for pain program

2025-09-12T09:20:11.000Z - 8 months ago

Apimeds Pharmaceuticals issues statement on FDA draft guidance for pain program

Apimeds Welcomes FDA Draft Guidance as Catalyst for Advancing Apitox Non-Opioid Pain Program

Sep 11, 2025, 9:54 PM EDT - 8 months ago

Apimeds Welcomes FDA Draft Guidance as Catalyst for Advancing Apitox Non-Opioid Pain Program

Apimeds Pharmaceuticals US, Inc. Partners with University of Alabama to Advance Biotech Business Development via ai² Future Labs

Aug 25, 2025, 2:11 PM EDT - 9 months ago

Apimeds Pharmaceuticals US, Inc. Partners with University of Alabama to Advance Biotech Business Development via ai² Future Labs

Apimeds Expands Leadership Team with Dr. Susan Kramer to Lead Product Development and Brian Peters to Lead its ai² Division

Jul 15, 2025, 5:34 PM EDT - 10 months ago

Apimeds Expands Leadership Team with Dr. Susan Kramer to Lead Product Development and Brian Peters to Lead its ai² Division

Apimeds Pharmaceuticals US, Inc. Announces Closing of Initial Public Offering

May 12, 2025, 5:14 PM EDT - 1 year ago

Apimeds Pharmaceuticals US, Inc. Announces Closing of Initial Public Offering

Apimeds Pharmaceuticals US, Inc. Announces Pricing of Initial Public Offering

May 8, 2025, 5:00 PM EDT - 1 year ago

Apimeds Pharmaceuticals US, Inc. Announces Pricing of Initial Public Offering

CoffeeRocks
CoffeeRocks May. 13 at 2:52 PM
$APUS Any price tag with recent dilution 10/1 RS Recently might affect the stock in the short term, looked at the financial, saw the RS
0 · Reply
JasonNewton
JasonNewton May. 9 at 7:21 PM
AMS is moving from an investment-heavy phase into a revenue-harvesting phase. The combination of: * expanding treatment centers, * rising direct patient revenue, * improving utilization, * international growth hopes, * and an extremely low float AMS hot watch. $ATXG $APUS $AGPU /.
0 · Reply
Bibby12
Bibby12 May. 8 at 3:10 PM
$APUS anybody understand share structure and Pipe.
1 · Reply
David_M_
David_M_ May. 8 at 4:12 AM
$APUS Up from here!
0 · Reply
CoffeeRocks
CoffeeRocks May. 7 at 8:22 PM
$CODX $GOVX $VRAX $APUS $BTAI Return of the BIO tickers
0 · Reply
Goat888
Goat888 May. 7 at 7:13 PM
$APUS I wanted to buy but people said 2 digits so I stopped
1 · Reply
Bibby12
Bibby12 May. 7 at 6:27 PM
$APUS bought some at 1.42. Not sure what the next catalyst will be but seems oversold at this point.
0 · Reply
Pinkfloyd35
Pinkfloyd35 May. 7 at 12:48 AM
$APUS total turd, don’t buy this .
0 · Reply
Nat21
Nat21 May. 6 at 11:48 PM
$APUS the companey which merged with $NAKA run from 0.60s to 30 plus dollars pre-merger. I hope we see a good run on $APUS before merger.
0 · Reply
TeeBee909
TeeBee909 May. 6 at 3:42 PM
$APUS not much needed (ask) for $3.X
0 · Reply
Goat888
Goat888 May. 6 at 1:57 PM
$APUS added more here
0 · Reply
Jdubb00
Jdubb00 May. 6 at 1:57 PM
$APUS Heating up
0 · Reply
Goat888
Goat888 May. 6 at 1:56 PM
$APUS easy 3+
0 · Reply
stockanalysis_
stockanalysis_ May. 6 at 1:17 PM
Premarket Losers: $WHLR $PRIM $ATOM.X $APUS $GMM Download this screener: https://stockanalysis.com/markets/premarket/losers/?ref=saveontrading
0 · Reply
Bibby12
Bibby12 May. 6 at 12:58 PM
$APUS they have the $ and approval in South Korea. US approval should be next.
0 · Reply
ItsallBS007
ItsallBS007 May. 6 at 12:10 PM
$APUS they getting only $10MM from the pipe. How $150MM cash ?? Why this should go up. It was a seller scam yesterday to run out and get bag holders in
0 · Reply
Camelinvesting
Camelinvesting May. 6 at 11:29 AM
$APUS oversold, should bounce imo
0 · Reply
TeeBee909
TeeBee909 May. 6 at 11:23 AM
$APUS: added more
0 · Reply
David_M_
David_M_ May. 6 at 11:13 AM
$APUS
0 · Reply
Camelinvesting
Camelinvesting May. 6 at 10:11 AM
$APUS logic my friend!
0 · Reply